In this study, we show for the first time that a single, EGFR‐TPMIL construct encapsulating a lipidated BPD molecule and irinotecan chemotherapy, is capable of simultaneously controlling tumor growth, remediating desmoplasia, and doubling survival. The gene discussed is EGFR; the disease is neoplasm.